Valuation: Izotropic Corporation

Market Cap 9.79M 8.7M 8.12M 7.4M 13.96M 942M 14.09M 98.29M 38.09M 481M 36.77M 35.97M 1.54B P/E 2027 *
-
P/E 2028 * -
Enterprise Value 9.79M 8.7M 8.12M 7.4M 13.96M 942M 14.09M 98.29M 38.09M 481M 36.77M 35.97M 1.54B EV / Sales 2027 *
1.96x
EV / Sales 2028 * 0.98x
Free-Float
92.14%
Yield 2027 *
-
Yield 2028 * -
1 week+2.63%
Current month-2.50%
1 month-17.02%
3 months-31.58%
6 months-15.22%
Current year-30.36%
1 week 0.19
Extreme 0.19
0.2
1 month 0.18
Extreme 0.175
0.28
Current year 0.18
Extreme 0.175
0.33
1 year 0.18
Extreme 0.175
0.49
3 years 0.04
Extreme 0.035
0.49
5 years 0.04
Extreme 0.035
1.24
10 years 0.04
Extreme 0.035
1.56
Manager TitleAgeSince
Chief Executive Officer 73 31/05/2023
Director of Finance/CFO 75 31/12/2022
Chief Operating Officer - 31/12/2022
Director TitleAgeSince
Director/Board Member 73 18/05/2016
Director/Board Member 51 21/05/2017
Director/Board Member 71 30/04/2017
Date Insider Type Main position Quantity % Market Cap. Importance
18/09/25 Option

Chief Financial Officer

100,000 0.1761%
18/09/25 Option

Chief Financial Officer

100,000 0.1761%
17/09/25 Sell

Chief Financial Officer

100,000 0.1761%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+2.63%-48.68%-2.50% 9.79M
+0.35%-2.99%+20.52%+31.06% 242B
+1.09%-4.65%-0.43%-0.76% 150B
-2.32%-3.27%-13.35%+36.07% 138B
-1.46%-3.01%-56.23%-17.35% 61.74B
-0.05%-1.32%+10.48%+22.34% 49.08B
+0.66%+0.19%-20.53%-20.70% 47.43B
+0.66%-2.90%+18.46%+52.17% 47.3B
-3.05%-2.62%-7.75%+36.49% 44.25B
-0.08%-1.92%+29.48%+60.45% 41.78B
Average -0.42%-2.50%-6.80%+19.73% 82.26B
Weighted average by Cap. -0.29%-3.27%+1.08%+21.95%

Financials

2027 *2028 *
Net sales 5M 4.44M 4.15M 3.78M 7.13M 481M 7.19M 50.18M 19.44M 246M 18.77M 18.37M 789M 10M 8.88M 8.29M 7.56M 14.26M 961M 14.39M 100M 38.89M 491M 37.54M 36.73M 1.58B
Net income 2.3M 2.04M 1.91M 1.74M 3.28M 221M 3.31M 23.09M 8.95M 113M 8.64M 8.45M 363M 6.23M 5.53M 5.16M 4.71M 8.88M 599M 8.96M 62.5M 24.22M 306M 23.38M 22.88M 982M
Net Debt - -
Logo Izotropic Corporation
Izotropic Corporation is a Canada-based medical device company. The Company is engaged in commercializing imaging-based products utilizing emerging technologies for the more accurate screening, diagnoses, and treatment of breast cancers. Its lzoView computed tomography (CT) Imaging System is intended to produce cross-sectional images of anatomy that can be imaged in the 30 cm aperture by computer reconstruction of x-ray transmission data for non-invasive visualization of tissue. The IzoView is for use in the non-invasive visualization of breast tissue, as an adjunct tool to mammography, by providing x-ray computer reconstructed images as an aid for qualified healthcare providers. The Company has not generated any revenue.
Employees
-
Date Price Change Volume
01/10/26 CA$0.1950 -2.50% 64,000
30/09/26 CA$0.2000 +2.56% 69,000
29/09/26 CA$0.1950 -2.50% 6,800
28/09/26 CA$0.2000 +5.26% 17,750
25/09/26 CA$0.1900 -5.00% 129,086

Quarterly revenue - Rate of surprise